Cagrilintide 5mg/3mL

What is Cagrilintide?

Cagrilintide is a long-acting amylin analogue currently under investigation as one of the most promising next-generation compounds in metabolic and weight management research. Designed to mimic the natural hormone amylin, it is being studied for its ability to influence appetite regulation and energy balance through distinct pathways from GLP-1 receptor agonists.

What makes Cagrilintide particularly exciting to researchers is its complementary mechanism — when studied alongside GLP-1 agonists, it may offer additive effects on metabolic outcomes, making it a key compound in combination peptide research.

Mechanism of Action

Cagrilintide is being studied for its potential to influence:

• Amylin receptor activation — mimics the natural satiety hormone released alongside insulin
• Appetite and food intake regulation — may reduce caloric consumption through central nervous system pathways
• Gastric emptying modulation — slows the rate at which food leaves the stomach, supporting satiety

Areas of Research

Current clinical and preclinical studies are evaluating Cagrilintide's potential role in:

• Body weight regulation and obesity management
• Appetite control and food intake reduction
• Combination metabolic therapy research
• Glucose and insulin response modulation

Research Use Only

This product is intended for laboratory research purposes only. It is not intended for human consumption, medical use, diagnosis, cure, mitigation, treatment, or prevention of any disease. This product has not been evaluated by the U.S. Food and Drug Administration (FDA). Purchasers are responsible for compliance with all applicable laws and regulations regarding the use and handling of research materials.